[HTML][HTML] Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy …
JA Simon, EA Stewart, S Jewell, M Li, MC Snabes - F&S Reports, 2024 - Elsevier
Objective To investigate efficacy of elagolix plus add-back therapy (1 mg estradiol and 0.5
mg norethindrone acetate once daily) on patient-reported nonbleeding symptoms and …
mg norethindrone acetate once daily) on patient-reported nonbleeding symptoms and …
[HTML][HTML] Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy …
JA Simon, EA Stewart, S Jewell, M Li, MC Snabes - F&S Reports - fertstertreports.org
Objective To investigate efficacy of elagolix plus add-back therapy (1 mg estradiol and 0.5
mg norethindrone acetate once daily) on patient-reported nonbleeding symptoms and …
mg norethindrone acetate once daily) on patient-reported nonbleeding symptoms and …